AIIMS developing portable tech to treat cervical cancer

The existing strategy of cervical cancer screening is Pap smear, which requires elaborate laboratory infrastructure and trained manpower, with low sensitivity that necessitates repeated testing 3-yearly.

AIIMS is developing an indigenous portable colposcope-cum-thermal ablator named Cerva for the treatment of cervical cancer patients. The new technique of thermal ablation permits screening in a single visit approach in suitable cases, in a simple 30-40 second-outpatient procedure.

The existing strategy of cervical cancer screening is Pap smear, which requires elaborate laboratory infrastructure and trained manpower, with low sensitivity that necessitates repeated testing 3-yearly.

With the emergence of HPV tests as the best method of testing, attention is now on the development of point-of-care HPV tests for immediate results.

HPV testing also has the advantage that a self-collected vaginal sample can be comparable to a physician-collected one.

This is useful for women in remote areas, or women who are hesitant and embarrassed to see a provider, but especially useful during the pandemic and beyond to avoid crowding in clinics or camps, experts say.

Source: Read Full Article